Exane Derivatives’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | $269 | Sell |
3
-461
| -99% | -$41.3K | ﹤0.01% | 646 |
|
2022
Q1 | $51.5K | Hold |
464
| – | – | 0.01% | 564 |
|
2021
Q4 | $48K | Sell |
464
-1,180
| -72% | -$122K | 0.01% | 495 |
|
2021
Q3 | $206K | Buy |
1,644
+909
| +124% | +$114K | 0.05% | 376 |
|
2021
Q2 | $93.6K | Sell |
735
-5,480
| -88% | -$698K | 0.02% | 534 |
|
2021
Q1 | $734K | Sell |
6,215
-804
| -11% | -$95K | 0.21% | 102 |
|
2020
Q4 | $822K | Buy |
7,019
+1,293
| +23% | +$151K | 0.24% | 100 |
|
2020
Q3 | $595K | Buy |
5,726
+707
| +14% | +$73.5K | 0.17% | 108 |
|
2020
Q2 | $460K | Buy |
5,019
+5,010
| +55,667% | +$459K | 0.12% | 134 |
|
2020
Q1 | $812 | Sell |
9
-147
| -94% | -$13.3K | ﹤0.01% | 529 |
|
2019
Q4 | $18.3K | Sell |
156
-7,098
| -98% | -$833K | ﹤0.01% | 382 |
|
2019
Q3 | $788K | Buy |
7,254
+5,926
| +446% | +$644K | 0.14% | 114 |
|
2019
Q2 | $129K | Buy |
1,328
+1,019
| +330% | +$99.2K | 0.02% | 285 |
|
2019
Q1 | $28.1K | Sell |
309
-125
| -29% | -$11.4K | 0.01% | 344 |
|
2018
Q4 | $39.5K | Hold |
434
| – | – | 0.01% | 351 |
|
2018
Q3 | $42.8K | Sell |
434
-147
| -25% | -$14.5K | 0.01% | 353 |
|
2018
Q2 | $50.2K | Sell |
581
-643
| -53% | -$55.5K | 0.01% | 356 |
|
2018
Q1 | $95.9K | Buy |
1,224
+382
| +45% | +$29.9K | 0.02% | 289 |
|
2017
Q4 | $68K | Buy |
+842
| New | +$68K | 0.01% | 291 |
|
2016
Q4 | – | Sell |
-1,058
| Closed | -$91.4K | – | 614 |
|
2016
Q3 | $91.4K | Buy |
+1,058
| New | +$91.4K | 0.01% | 221 |
|
2016
Q2 | – | Sell |
-515
| Closed | -$38.6K | – | 578 |
|
2016
Q1 | $38.6K | Sell |
515
-707
| -58% | -$53K | 0.01% | 298 |
|
2015
Q4 | $94K | Sell |
1,222
-3,487
| -74% | -$268K | 0.01% | 190 |
|
2015
Q3 | $315K | Buy |
4,709
+816
| +21% | +$54.6K | 0.04% | 136 |
|
2015
Q2 | $288K | Hold |
3,893
| – | – | 0.03% | 163 |
|
2015
Q1 | $304K | Buy |
3,893
+1,690
| +77% | +$132K | 0.03% | 153 |
|
2014
Q4 | $159K | Buy |
+2,203
| New | +$159K | 0.02% | 216 |
|